Sally Martin

Dr Sally Martin


School of Biomedicine

Faculty of Health and Medical Sciences

Dr Martin is currently a post-doctoral researcher in the Myeloma Research Laboratory, School of Medical Sciences, University of Adelaide, based at the SAHMRI, Cancer Theme.

Dr Martin's PhD research, completed in 2009, centred on bone marrow angiogenesis and osteolytic bone disease in the haematological malignancy, multiple myeloma. Since completing her PhD studies, Dr Martin has been examining the role of the PI3K and mTOR signalling pathways in bone development, looking at ways to exploit these pathways to stimulate bone formation in disease settings such as osteoporosis and tumour-associated bone loss.

Dr Martin is an affiliate lecturer in the School of Medical Sciences and the School of Medicine, University of Adelaide.

Dr Martin's current research projects are focussed on (1) the role of the mTOR signalling pathways in mesenchymal stem cell biology, (2) the role of the mTOR signalling pathways in regulating skeletal biology and bone remodelling, and (3) the role of skeletal mTORC1 signalling in B-cell development and glucose homeostasis.

  • Appointments

    Date Position Institution name
    2015 - ongoing Post-doctoral Researcher University of Adelaide, Adelaide
    2013 - ongoing Affiliate Lecturer University of Adelaide
    2012 - ongoing Affiliate Lecturer University of Adelaide
    2009 - 2015 Post-doctoral Researcher SA Pathology
    2003 - 2008 Technical Assistant (part-time) Institute of Medical and Veterinary Science (IMVS)
  • Education

    Date Institution name Country Title
    2005 - 2008 University of Adelaide, Adelaide Australia PhD
    2000 - 2004 University of South Australia Australia Bachelor of Medical and Pharmaceutical Biotechnology (Hons)

Mary Overton Early Career Research Fellowship (2012 - 2015), The role of the raptor and rictor signalling pathways in skeletal biology, AUD$252,000

Centre for Stem Cell Research Project Grant 2012, The role of raptor and rictor in MSC differentiation, AUD$75,000

Novartis Pharmaceuticals Project Grant 2011, Can the dual PI3K/mTOR inhibitor NVP-BEZ235 be used to stimulate bone formation in multiple myeloma? AUD$75,000.

  • Past Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2017 - 2020 Co-Supervisor The Role of Osteoblast-mTORC1 in the Regulation of Glucose Metabolism Doctor of Philosophy Doctorate Full Time Miss Pawanrat Tangseefa
    2013 - 2018 Co-Supervisor The Role of mTORC1 in Mesenchymal Stem Cell Fate Determination, Osteoblast Differentiation and Skeletal Development Doctor of Philosophy Doctorate Part Time Ms Mary Patricia Matthews
  • Position: Lecturer
  • Email:
  • Campus: North Terrace
  • Building: Helen Mayo North, floor 2
  • Org Unit: Medical Sciences

Connect With Me
External Profiles